Malaria Consortium US Donate

Publications

Explore our publications to find useful evidence, lessons and recommendations from our work across Africa and Asia

INTERACTIVE PUBLICATIONS SIGN UP TO THE NEWSLETTER
Reset all search optionsCurrent search filters (128 results match ALL terms):
Seasonal malaria chemoprevention
22/10/2023 Presentation Seasonal malaria chemoprevention effectiveness in Northern Mozambique: Results from a cluster-randomised controlled trial After adjusting for relevant variables on an intention-to-treat basis, seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine effectively prevented clinical malaria in eligible children during the peak transmission season in northern… 22/10/2023 After adjusting for relevant variables on an intention-to-treat basis, seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine effectively prevented clinical malaria in eligible children during the peak transmission season in northern Mozambique.
21/10/2023 Poster Quasi-experimental study to estimate the effectiveness of seasonal malaria chemoprevention in South Sudan In South Sudan, seasonal malaria chemoprevention reduced malaria in children during the high transmission season, despite potential high levels of resistance. 21/10/2023 In South Sudan, seasonal malaria chemoprevention reduced malaria in children during the high transmission season, despite potential high levels of resistance.
21/10/2023 Poster Development and evaluation of a novel protocol to assess the efficacy of seasonal malaria chemoprevention using sulfadoxine, pyrimethamine and amodiaquine in an area of high drug resistance in Nampula, Mozambique Seasonal malaria chemoprevention with SPAQ is preventing clinical disease but is not preventing new sub-patent infections over 28 days despite therapeutic drug levels, suggesting prevention of clinical disease may be… 21/10/2023 Seasonal malaria chemoprevention with SPAQ is preventing clinical disease but is not preventing new sub-patent infections over 28 days despite therapeutic drug levels, suggesting prevention of clinical disease may be short-lived.
21/10/2023 Presentation Chemoprevention options from seasonal malaria chemoprevention non-eligible areas: Experiences from Nigeria Following the development of a malaria stratification map for Nigeria, a study is being carried out to assess the impact and operational feasibility of perennial malaria chemoprevention in Osun state. 21/10/2023 Following the development of a malaria stratification map for Nigeria, a study is being carried out to assess the impact and operational feasibility of perennial malaria chemoprevention in Osun state.
21/10/2023 Presentation Rapid assessments for the deployment of seasonal malaria chemoprevention in new geographies of East and southern Africa A rapid assessment will estimate the effectiveness, chemoprevention efficacy, potential deployment impact, acceptability and feasibility of seasonal malaria chemoprevention using SPAQ in new geographies within East and southern Africa. 21/10/2023 A rapid assessment will estimate the effectiveness, chemoprevention efficacy, potential deployment impact, acceptability and feasibility of seasonal malaria chemoprevention using SPAQ in new geographies within East and southern Africa.
20/10/2023 Poster Caregiver knowledge and confidence in seasonal malaria chemoprevention effectiveness in Nigeria The more knowledgeable caregivers are about seasonal malaria chemoprevention, the more confidence they will have in its effectiveness. 20/10/2023 The more knowledgeable caregivers are about seasonal malaria chemoprevention, the more confidence they will have in its effectiveness.
20/10/2023 Poster Assessing the impact of extending seasonal malaria chemoprevention from four to five monthly cycles in Burkina Faso Extending seasonal malaria chemoprevention from four to five cycles was associated with further reductions in malaria incidence and deaths in Burkina Faso. 20/10/2023 Extending seasonal malaria chemoprevention from four to five cycles was associated with further reductions in malaria incidence and deaths in Burkina Faso.
20/10/2023 Poster Perceived factors impacting community health workers and lead mothers’ capacity to support seasonal malaria chemoprevention across delivery settings: Qualitative secondary analysis from recent studies in Mozambique, Nigeria, South Sudan and Uganda Challenges in access, community sensitisation, workload and context can affect community health workers and lead mothers’ ability to support SMC campaigns. 20/10/2023 Challenges in access, community sensitisation, workload and context can affect community health workers and lead mothers’ ability to support SMC campaigns.
20/10/2023 Poster Exploring community perceptions on the feasibility and acceptability of seasonal malaria chemoprevention The commitment and trust of community health workers increase the feasibility and acceptability of seasonal malaria chemoprevention. 20/10/2023 The commitment and trust of community health workers increase the feasibility and acceptability of seasonal malaria chemoprevention.
20/10/2023 Poster Health-seeking behaviours and beliefs surrounding malaria in three East and southern African geographies introducing seasonal malaria chemoprevention: A secondary qualitative analysis Context-specific data on health-seeking behaviours and beliefs surrounding malaria should be used to strengthen community engagement and health messaging. 20/10/2023 Context-specific data on health-seeking behaviours and beliefs surrounding malaria should be used to strengthen community engagement and health messaging.
20/10/2023 Poster Molecular surveillance of sulfadoxine-pyrimethamine and amodiaquine resistance markers in northeastern Uganda Seasonal malaria chemoprevention has not notably altered sulfadoxine-pyrimethamine resistance after two consecutive annual rounds in northeastern Uganda. 20/10/2023 Seasonal malaria chemoprevention has not notably altered sulfadoxine-pyrimethamine resistance after two consecutive annual rounds in northeastern Uganda.
20/10/2023 Poster Assessing coverage and quality of seasonal malaria chemoprevention before and during scale-up in Uganda Seasonal malaria chemoprevention was successfully scaled up in the Karamoja region of Uganda, a new geographical context, achieving good coverage and quality. 20/10/2023 Seasonal malaria chemoprevention was successfully scaled up in the Karamoja region of Uganda, a new geographical context, achieving good coverage and quality.
20/10/2023 Poster The role of community distributors in ensuring the quality delivery of seasonal malaria chemoprevention in Nigeria Directly observed treatment practised by community distributors is critical for the quality delivery of seasonal malaria chemoprevention. 20/10/2023 Directly observed treatment practised by community distributors is critical for the quality delivery of seasonal malaria chemoprevention.
20/10/2023 Poster The impact of seasonal malaria chemoprevention on Plasmodium falciparum resistance to sulfadoxine-pyrimethamine and amodiaquine in northern Mozambique Monitoring resistance markers is essential as Mozambique expands seasonal malaria chemoprevention and introduces new chemoprevention strategies. 20/10/2023 Monitoring resistance markers is essential as Mozambique expands seasonal malaria chemoprevention and introduces new chemoprevention strategies.
20/10/2023 Poster Analysing age-related trends in routine data through transmission modelling during seasonal malaria chemoprevention in Burkina Faso Age-related variations in routine data can be attributed to non-malarial fevers and treatment-seeking behaviours, which mask the impact of seasonal malaria chemoprevention. 20/10/2023 Age-related variations in routine data can be attributed to non-malarial fevers and treatment-seeking behaviours, which mask the impact of seasonal malaria chemoprevention.
19/10/2023 Poster Assessing coverage and quality of seasonal malaria chemoprevention in previously untreated areas of Mozambique Routinely monitoring SMC coverage and quality can identify areas for improvement, particularly in previously untreated areas. 19/10/2023 Routinely monitoring SMC coverage and quality can identify areas for improvement, particularly in previously untreated areas.
19/10/2023 Poster Community leadership in seasonal malaria chemoprevention: Engaging communities in northern Mozambique The involvement of community leaders contributed to the high acceptability of seasonal malaria chemoprevention. 19/10/2023 The involvement of community leaders contributed to the high acceptability of seasonal malaria chemoprevention.
19/10/2023 Poster Assessing age compliance during seasonal malaria chemoprevention in nine states in Nigeria The administration of seasonal malaria chemoprevention medicines to age-ineligible children is common. Understanding associated causes will enhance the quality of programmes. 19/10/2023 The administration of seasonal malaria chemoprevention medicines to age-ineligible children is common. Understanding associated causes will enhance the quality of programmes.
19/10/2023 Poster Resistance markers to sulfadoxine-pyrimethamine and amodiaquine in the context of seasonal malaria chemoprevention in Burkina Faso Sulfadoxine-pyrimethamine and amodiaquine remain effective after eight years of SMC implementation in Burkina Faso. 19/10/2023 Sulfadoxine-pyrimethamine and amodiaquine remain effective after eight years of SMC implementation in Burkina Faso.
19/10/2023 Presentation A cluster randomised controlled non-inferiority trial to assess the protective effectiveness of SPAQ and DP for SMC among children 3–59 months, in the context of high parasite resistance, Karamoja region Sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) and dihydroartemisinin piperaquine (DP) were both highly effective at preventing clinical malaria in eligible children during the high transmission season in Karamoja region, Uganda. 19/10/2023 Sulfadoxine-pyrimethamine plus amodiaquine (SPAQ) and dihydroartemisinin piperaquine (DP) were both highly effective at preventing clinical malaria in eligible children during the high transmission season in Karamoja region, Uganda.
13/09/2023 Learning brief Supporting the scale-up of seasonal malaria chemoprevention in Mozambique Malaria Consortium Mozambique visited Nigeria to gather practical knowledge on the effective scale-up of seasonal malaria chemoprevention, and to establish ways of exchanging knowledge in the future. 13/09/2023 Malaria Consortium Mozambique visited Nigeria to gather practical knowledge on the effective scale-up of seasonal malaria chemoprevention, and to establish ways of exchanging knowledge in the future.
11/07/2023 Project brief Conducting rapid assessments to build the evidence base for seasonal malaria chemoprevention in new geographies We are carrying out rapid assessments in up to five countries across East and southern Africa where SMC has not previously been delivered at scale. 11/07/2023 We are carrying out rapid assessments in up to five countries across East and southern Africa where SMC has not previously been delivered at scale.
05/05/2023 Journal article Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad and Togo Non-adherence to amodiaquine administration by caregivers has implications for the emergence of antimalarial resistance. 05/05/2023 Non-adherence to amodiaquine administration by caregivers has implications for the emergence of antimalarial resistance.
25/04/2023 Project report Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2022 This report outlines our methods for monitoring coverage of our SMC programme and the quality of its delivery in 2022. 25/04/2023 This report outlines our methods for monitoring coverage of our SMC programme and the quality of its delivery in 2022.
25/04/2023 Project report Malaria Consortium’s seasonal malaria chemoprevention programme: Philanthropy report 2022 This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC. 25/04/2023 This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC.
30/03/2023 Learning brief Implementing seasonal malaria chemoprevention in conflict-affected areas in Borno state Despite security challenges, SMC could safely be delivered to eligible children and hard-to-reach populations in Borno state, Nigeria, in 2021. 30/03/2023 Despite security challenges, SMC could safely be delivered to eligible children and hard-to-reach populations in Borno state, Nigeria, in 2021.
30/01/2023 Journal article A hybrid effectiveness-implementation study protocol to assess the effectiveness and chemoprevention efficacy of implementing seasonal malaria chemoprevention in five districts in Karamoja region, Uganda The study aims to test the effectiveness and safety of DP-SMC and SPAQ-SMC among 3–59 months old children in Karamoja region, Uganda. 30/01/2023 The study aims to test the effectiveness and safety of DP-SMC and SPAQ-SMC among 3–59 months old children in Karamoja region, Uganda.
12/01/2023 Journal article Optimising the role of ‘lead mothers’ in seasonal malaria chemoprevention campaigns: Formative research in Kano state, northern Nigeria Lead mothers can and do influence caregivers to adopt healthy behaviours during SMC campaigns. But their recruitment, training and supervision can be improved. 12/01/2023 Lead mothers can and do influence caregivers to adopt healthy behaviours during SMC campaigns. But their recruitment, training and supervision can be improved.
12/12/2022 Presentation Evaluation of the impact of one round of seasonal malaria chemoprevention on resistance markers associated with sulfadoxine-pyrimethamine and amodiaquine in Karamoja, Uganda, March 2022 One round of SMC with SPAQ does not appear to select for an observable change in resistance markers for SP and AQ. 12/12/2022 One round of SMC with SPAQ does not appear to select for an observable change in resistance markers for SP and AQ.
03/11/2022 Presentation A non-randomised controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda With the National Malaria Control Division, we conducted an SMC implementation study in Karamoja, where parasite resistance is assumed to be high. 03/11/2022 With the National Malaria Control Division, we conducted an SMC implementation study in Karamoja, where parasite resistance is assumed to be high.
03/11/2022 Presentation Seasonal malaria chemoprevention: New geographies in Nigeria and quality of SMC delivery Coverage survey results show good performance on the SMC quality indicators, including caregivers’ satisfaction and coverage of the intervention. 03/11/2022 Coverage survey results show good performance on the SMC quality indicators, including caregivers’ satisfaction and coverage of the intervention.
02/11/2022 Poster Assessing the quality of SMC delivery by village health teams in Uganda With sufficient training and stakeholder engagement, village health teams in Uganda can deliver high-quality SMC. 02/11/2022 With sufficient training and stakeholder engagement, village health teams in Uganda can deliver high-quality SMC.
02/11/2022 Poster Evaluating the adaptation of SMC implementation during COVID-19 in Karamoja, Uganda The Sahel’s SMC implementation model is feasible in Uganda. We recommend scale-up in line with WHO guidelines. 02/11/2022 The Sahel’s SMC implementation model is feasible in Uganda. We recommend scale-up in line with WHO guidelines.
02/11/2022 Presentation A cross-sectional survey to assess the feasibility and acceptability of SMC among nomadic pastoralist population, Uganda With the National Malaria Control Division, we conducted an SMC implementation study in two districts of Karamoja to assess its suitability amongst nomadic pastoralists. 02/11/2022 With the National Malaria Control Division, we conducted an SMC implementation study in two districts of Karamoja to assess its suitability amongst nomadic pastoralists.
02/11/2022 Poster Acceptability of seasonal malaria chemoprevention among children under five in Mozambique: A qualitative study SMC was highly accepted as a strategy to prevent malaria among children 3–59 months in Mozambique. 02/11/2022 SMC was highly accepted as a strategy to prevent malaria among children 3–59 months in Mozambique.
01/11/2022 Poster Harnessing the SMC campaign in Nigeria: Safety, equity and cost of fully integrating vitamin A supplementation Integrating VAS with SMC is safe, feasible, acceptable to communities and implementers, and can be achieved at minimal additional cost. 01/11/2022 Integrating VAS with SMC is safe, feasible, acceptable to communities and implementers, and can be achieved at minimal additional cost.
01/11/2022 Poster Feasibility and acceptability of extending delivery of SMC to children aged 5–10 years in Chad Stakeholders support extending SMC to older children, but believe children 3–59 months should be reached first. 01/11/2022 Stakeholders support extending SMC to older children, but believe children 3–59 months should be reached first.
01/11/2022 Poster Impact assessment of SMC using routine health surveillance data in Kogi state, Nigeria Routine data can measure SMC impact if appropriate methods for selecting a comparison group are used. 01/11/2022 Routine data can measure SMC impact if appropriate methods for selecting a comparison group are used.
01/11/2022 Poster Integrating gender into the process evaluation of SMC in Karamoja, Uganda: Results and future directions A gender-sensitive lens highlights complex roles, bargaining strategies, gaps and barriers for SMC programmes to monitor and address. 01/11/2022 A gender-sensitive lens highlights complex roles, bargaining strategies, gaps and barriers for SMC programmes to monitor and address.
31/10/2022 Poster Facilitators of, and barriers to, fully integrating SMC with vitamin A supplementation: A qualitative enquiry Full integration of SMC and vitamin A supplementation at scale is feasible and acceptable. 31/10/2022 Full integration of SMC and vitamin A supplementation at scale is feasible and acceptable.
31/10/2022 Poster Using the role model approach to identify best practices and challenges during SMC drug administration in Burkina Faso Through the role model approach, several identified behaviours in the community helped to improve the administration of SMC medicines. 31/10/2022 Through the role model approach, several identified behaviours in the community helped to improve the administration of SMC medicines.
31/10/2022 Poster Exploring the role model approach to strengthen the administration of SMC medicines in Chad The role model approach supports caregivers to administer SMC medicines more effectively. 31/10/2022 The role model approach supports caregivers to administer SMC medicines more effectively.
31/10/2022 Poster Optimising the role of lead mothers in SMC campaigns: Insights from formative research in Kano state, northern Nigeria Lead mothers can influence caregivers to adopt positive malaria prevention behaviours, but their recruitment and supervision could be improved. 31/10/2022 Lead mothers can influence caregivers to adopt positive malaria prevention behaviours, but their recruitment and supervision could be improved.
31/10/2022 Poster Measuring the impact of SMC on malaria prevalence and case distribution compared to predicted estimates from a transmission model in Burkina Faso Analysing prevalence trends and age distribution of cases is a useful method for estimating the impact of SMC in Burkina Faso. 31/10/2022 Analysing prevalence trends and age distribution of cases is a useful method for estimating the impact of SMC in Burkina Faso.
31/08/2022 Annual review Trustees’ report and financial statements for the year to 31 March 2022 Malaria Consortium's trustees present their report and the audited financial statements for the year which ended 31 March 2022. 31/08/2022 Malaria Consortium's trustees present their report and the audited financial statements for the year which ended 31 March 2022.
12/08/2022 Synopsis Exploring the use of seasonal malaria chemoprevention in South Sudan This study seeks to understand the feasibility, acceptability and effectiveness of SMC in South Sudan and explores scalability of SMC in other states. 12/08/2022 This study seeks to understand the feasibility, acceptability and effectiveness of SMC in South Sudan and explores scalability of SMC in other states.
27/04/2022 Advocacy brief Maximising resources for healthcare: Integrating vitamin A supplementation with seasonal malaria chemoprevention Scaling up an integrated vitamin A supplementation and SMC campaign addresses coverage gaps and reduces under-five mortality in Nigeria. 27/04/2022 Scaling up an integrated vitamin A supplementation and SMC campaign addresses coverage gaps and reduces under-five mortality in Nigeria.
25/04/2022 Project report Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2021 This report outlines our methods for monitoring coverage of our SMC programme and the quality of its delivery in 2021. 25/04/2022 This report outlines our methods for monitoring coverage of our SMC programme and the quality of its delivery in 2021.
25/04/2022 Project report Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2021 This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC. 25/04/2022 This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC.
21/04/2022 Learning brief Integrating seasonal malaria chemoprevention and vitamin A supplementation: Lessons learnt from Nigeria Integrating vitamin A supplementation into the SMC campaign in Bauchi state, Nigeria, was feasible and accepted by implementers and communities. 21/04/2022 Integrating vitamin A supplementation into the SMC campaign in Bauchi state, Nigeria, was feasible and accepted by implementers and communities.
14/03/2022 Insight brief Insights from implementing the first seasonal malaria chemoprevention campaign in Mozambique Between November 2020 and February 2021, we implemented four monthly SMC cycles in Nampula province. 14/03/2022 Between November 2020 and February 2021, we implemented four monthly SMC cycles in Nampula province.
01/03/2022 Journal article Extending delivery of seasonal malaria chemoprevention to children aged 5–10 years in Chad: A mixed-methods study This study was conducted in Massaguet health district in Hadjer Lamis province, where SMC has been implemented since 2015. 01/03/2022 This study was conducted in Massaguet health district in Hadjer Lamis province, where SMC has been implemented since 2015.
04/02/2022 Technical brief Monitoring and evaluating seasonal malaria chemoprevention using a logical framework approach Malaria Consortium has developed a comprehensive framework for monitoring and evaluating SMC programmes. 04/02/2022 Malaria Consortium has developed a comprehensive framework for monitoring and evaluating SMC programmes.
16/12/2021 Project brief Improving vitamin A coverage through co-implementation with seasonal malaria chemoprevention This study aims to generate evidence to support decision-making on integrating vitamin A supplementation into SMC in Nigeria. 16/12/2021 This study aims to generate evidence to support decision-making on integrating vitamin A supplementation into SMC in Nigeria.
09/12/2021 Synopsis Optimising the role of lead mothers during the seasonal malaria chemoprevention campaign in Kano state, Nigeria This study focuses on optimising the role of lead mothers, women who promote health activities in their communities, during the SMC campaign in Kano, Nigeria. 09/12/2021 This study focuses on optimising the role of lead mothers, women who promote health activities in their communities, during the SMC campaign in Kano, Nigeria.
30/11/2021 Infographic Webinar: Taking seasonal malaria chemoprevention to new geographies In our webinar we are exploring if SMC can be deployed in areas in Africa outside the Sahel where malaria transmission is seasonal. 30/11/2021 In our webinar we are exploring if SMC can be deployed in areas in Africa outside the Sahel where malaria transmission is seasonal.
20/11/2021 Poster Feasibility, acceptability and protective effectiveness of seasonal malaria chemoprevention in Uganda SMC with SPAQ is feasible, acceptable and demonstrates good protective effectiveness against malaria morbidity in the Karamoja region. 20/11/2021 SMC with SPAQ is feasible, acceptable and demonstrates good protective effectiveness against malaria morbidity in the Karamoja region.
20/11/2021 Poster Impact of seasonal malaria chemoprevention on the prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria The impact of SMC can be seen in malaria infection prevalence data collected through regular household surveys. 20/11/2021 The impact of SMC can be seen in malaria infection prevalence data collected through regular household surveys.
20/11/2021 Presentation Seasonal malaria chemoprevention: Results from Mozambique implementation study 2020–2021 This presentation gives an overview of the Mozambique SMC implementation study. 20/11/2021 This presentation gives an overview of the Mozambique SMC implementation study.
16/11/2021 Poster Improving vitamin A coverage through integration with seasonal malaria chemoprevention in Nigeria SMC is a viable platform to improve vitamin A coverage and access among children under five in low- and middle-income countries. 16/11/2021 SMC is a viable platform to improve vitamin A coverage and access among children under five in low- and middle-income countries.
16/11/2021 Poster Factors predicting adherence to day two and day three seasonal malaria chemoprevention administration in four Sahelian countries Home visits by lead mothers and sensitisation about SMC dates and medicines can enhance caregiver adherence to administration of amodiaquine. 16/11/2021 Home visits by lead mothers and sensitisation about SMC dates and medicines can enhance caregiver adherence to administration of amodiaquine.
16/11/2021 Poster Exploring a role model approach to improve caregiver administration of seasonal malaria chemoprevention drugs to children under five in Burkina Faso, Chad and Togo The role model approach provides valuable insights to support improved administration of SMC medicines by caregivers. 16/11/2021 The role model approach provides valuable insights to support improved administration of SMC medicines by caregivers.
16/11/2021 Poster Adaptation of rapid multi-objective LQAS surveys in Burkina Faso, Chad, Nigeria, Mozambique and Togo to drive improvements in SMC delivery Lot quality assurance sampling (LQAS) was successfully used to rapidly improve data use and improve decision-making for programmes in SMC-implementing countries. 16/11/2021 Lot quality assurance sampling (LQAS) was successfully used to rapidly improve data use and improve decision-making for programmes in SMC-implementing countries.
18/10/2021 Journal article Modelled impact of seasonal malaria chemoprevention on district-level suspected and confirmed malaria cases in Chad based on routine clinical data (2013–2018) This study presents a solution for employing readily available routine data to evaluate the impact of health interventions at scale without extensive covariate data. 18/10/2021 This study presents a solution for employing readily available routine data to evaluate the impact of health interventions at scale without extensive covariate data.
15/10/2021 Project report A mixed-methods study to assess the quality of infection prevention and control measures during delivery of seasonal malaria chemoprevention in Sokoto and Kano states, northern Nigeria This study determines adherence to, and perceptions of, infection prevention and control measures when delivering SMC during the COVID-19 pandemic. 15/10/2021 This study determines adherence to, and perceptions of, infection prevention and control measures when delivering SMC during the COVID-19 pandemic.
17/09/2021 Journal article Assessment of the feasibility, acceptability and impact of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique This study provides a unique contribution to the evidence on the prevalence of SPAQ resistance in Mozambique and will inform future SMC implementation. 17/09/2021 This study provides a unique contribution to the evidence on the prevalence of SPAQ resistance in Mozambique and will inform future SMC implementation.
09/09/2021 Synopsis Using the role model approach to improve administration of seasonal malaria chemoprevention drugs in Burkina Faso, Chad and Togo During COVID-19, many caregivers found it challenging to adapt administration of antimalarial medicines to minimise physical contact between distributors and children. 09/09/2021 During COVID-19, many caregivers found it challenging to adapt administration of antimalarial medicines to minimise physical contact between distributors and children.
08/09/2021 Journal article Effectiveness of seasonal malaria chemoprevention treatments when SMC is implemented at scale This study found that SMC was highly effective in preventing clinical malaria when delivered at scale through national malaria control programmes. 08/09/2021 This study found that SMC was highly effective in preventing clinical malaria when delivered at scale through national malaria control programmes.
06/09/2021 Research brief Exploring the implementation of seasonal malaria chemoprevention in Mozambique SMC was delivered for the first time in Mozambique in 2020–2021, achieving very high coverage of households and eligible children. 06/09/2021 SMC was delivered for the first time in Mozambique in 2020–2021, achieving very high coverage of households and eligible children.
15/07/2021 Research brief Feasibility and acceptability of extending seasonal malaria chemoprevention to children aged 5–10 years This study aimed to understand the barriers to delivering SMC in Massaguet district, Chad, to children above 59 months. 15/07/2021 This study aimed to understand the barriers to delivering SMC in Massaguet district, Chad, to children above 59 months.
09/06/2021 Brochure Malaria Consortium Burkina Faso We are carrying out SMC programmes across Burkina Faso and are exploring the potential of digital solutions to strengthen health systems in the country. 09/06/2021 We are carrying out SMC programmes across Burkina Faso and are exploring the potential of digital solutions to strengthen health systems in the country.
02/06/2021 Project brief Chimioprévention du paludisme saisonnier: Protéger les enfants de moins de cinq ans contre le paludisme durant les pics de transmission saisonniers En 2021, notre programme vise à atteindre 20 millions d’enfants au Burkina Faso, au Tchad, au Nigéria et au Togo. 02/06/2021 En 2021, notre programme vise à atteindre 20 millions d’enfants au Burkina Faso, au Tchad, au Nigéria et au Togo.
02/06/2021 Synopsis Evaluating the feasibility, acceptability and protective effectiveness of seasonal malaria chemoprevention in Karamoja, Uganda With our study, we aim to inform malaria decision-making, policy change and strengthen existing interventions to further reduce malaria morbidity and mortality. 02/06/2021 With our study, we aim to inform malaria decision-making, policy change and strengthen existing interventions to further reduce malaria morbidity and mortality.
13/05/2021 Project brief Seasonal malaria chemoprevention: Protecting children under five from malaria during peak transmission season In 2021, Malaria Consortium's SMC programme aims to reach 20 million children in Burkina Faso, Chad, Nigeria and Togo. 13/05/2021 In 2021, Malaria Consortium's SMC programme aims to reach 20 million children in Burkina Faso, Chad, Nigeria and Togo.
29/04/2021 Learning paper Implementing mass campaigns during a pandemic: What we learnt from supporting seasonal malaria chemoprevention during COVID-19 Key learnings from supporting SMC implementation during the pandemic give invaluable insights that can inform future SMC implementation. 29/04/2021 Key learnings from supporting SMC implementation during the pandemic give invaluable insights that can inform future SMC implementation.
16/04/2021 Project report Quantitative report on seasonal malaria chemoprevention supported by Malaria Consortium in 2020: Coverage and quality in Burkina Faso, Chad, Nigeria and Togo This report outlines methods employed by Malaria Consortium for monitoring coverage of its SMC programme and the quality of SMC delivery in 2020. 16/04/2021 This report outlines methods employed by Malaria Consortium for monitoring coverage of its SMC programme and the quality of SMC delivery in 2020.
16/04/2021 Project report Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 Malaria Consortium’s annual report on the use of philanthropic funding for SMC. 16/04/2021 Malaria Consortium’s annual report on the use of philanthropic funding for SMC.
29/01/2021 Journal article Seasonal malaria chemoprevention in the Sahel subregion of Africa: A cost-effectiveness and cost-savings analysis This study provides timely and important evidence on the cost, cost-effectiveness and potential cost savings of the first large-scale, multi-country SMC campaign. 29/01/2021 This study provides timely and important evidence on the cost, cost-effectiveness and potential cost savings of the first large-scale, multi-country SMC campaign.
14/12/2020 Journal article COVID-19 knowledge, beliefs, prevention behaviours and misinformation in the context of an adapted seasonal malaria chemoprevention campaign in six northern Nigerian states In response to the global COVID-19 pandemic, we adapted our SMC delivery model to ensure safety of distributors, data collectors and communities. 14/12/2020 In response to the global COVID-19 pandemic, we adapted our SMC delivery model to ensure safety of distributors, data collectors and communities.
05/12/2020 Journal article Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: An observational study This study evaluates the ACCESS-SMC project, which sought to remove barriers to SMC scale-up in seven countries in 2015–2016. 05/12/2020 This study evaluates the ACCESS-SMC project, which sought to remove barriers to SMC scale-up in seven countries in 2015–2016.
26/11/2020 Synopsis Assessing the usability of a geospatial platform for seasonal malaria chemoprevention We are piloting the use of a geospatial platform called Reveal to support the planning, distribution and tracking of SMC in northern Nigeria. 26/11/2020 We are piloting the use of a geospatial platform called Reveal to support the planning, distribution and tracking of SMC in northern Nigeria.
19/11/2020 Presentation Piloting Reveal for use in seasonal malaria chemoprevention in Nigeria This presentation gives an overview of a new pilot study that explores the possibility of digitising the management of SMC via the Reveal platform. 19/11/2020 This presentation gives an overview of a new pilot study that explores the possibility of digitising the management of SMC via the Reveal platform.
18/11/2020 Presentation Assessing the impact of seasonal malaria chemoprevention on suspected and confirmed malaria cases in Chad using routine clinical data, 2013–2018 This presentation aims to generate evidence on the impact of SMC at scale. 18/11/2020 This presentation aims to generate evidence on the impact of SMC at scale.
18/11/2020 Presentation Extending seasonal malaria chemoprevention to five cycles: A feasibility and acceptability study in Cascades region, Burkina Faso This presentation examines the feasibility and acceptability of extending SMC to five cycles in Burkina Faso. 18/11/2020 This presentation examines the feasibility and acceptability of extending SMC to five cycles in Burkina Faso.
18/11/2020 Presentation An ecological analysis exploring the impact of seasonal malaria chemoprevention in Burkina Faso using national household surveys (2010–2017)​ This presentation investigates whether the effect of SMC can be observed in household data, and to add to the evidence base of SMC impact when implemented at scale​. 18/11/2020 This presentation investigates whether the effect of SMC can be observed in household data, and to add to the evidence base of SMC impact when implemented at scale​.
18/11/2020 Poster Measuring the impact of seasonal malaria chemoprevention in Nigeria using propensity score matching for counterfactuals (2017–2019) Propensity score matching could be a suitable method to determine the impact of SMC when routine data analysis is inadequate. 18/11/2020 Propensity score matching could be a suitable method to determine the impact of SMC when routine data analysis is inadequate.
18/11/2020 Poster Perceptions of the feasibility and acceptability of extending the delivery of seasonal malaria chemoprevention to older children in Chad Extending SMC to older children is widely considered acceptable. 18/11/2020 Extending SMC to older children is widely considered acceptable.
17/11/2020 Poster Pharmacovigilance in seasonal malaria chemoprevention in northern Nigeria Pharmacovigilance is well integrated in SMC, yet reporting of suspected adverse medicine reactions is low. 17/11/2020 Pharmacovigilance is well integrated in SMC, yet reporting of suspected adverse medicine reactions is low.
17/11/2020 Poster Investigating fever occurrence among under-fives and seasonal malaria chemoprevention protocol adherence in northern Nigeria Quality delivery of SMC significantly reduces fever occurrence in under-fives when used alongside insecticide-treated nets. 17/11/2020 Quality delivery of SMC significantly reduces fever occurrence in under-fives when used alongside insecticide-treated nets.
16/11/2020 Presentation Co-implementing vitamin A supplementation with seasonal malaria chemoprevention in Sokoto state, Nigeria: A feasibility study​ This presentation explores the feasibility and acceptability of co-delivering vitamin A supplementation via the SMC campaign. 16/11/2020 This presentation explores the feasibility and acceptability of co-delivering vitamin A supplementation via the SMC campaign.
02/11/2020 Synopsis Assessing adherence to infection prevention and control measures for seasonal malaria chemoprevention during COVID-19 This study will explore community distributors’ adherence to infection prevention and control practices for SMC in Burkina Faso, Chad and Nigeria during COVID-19. 02/11/2020 This study will explore community distributors’ adherence to infection prevention and control practices for SMC in Burkina Faso, Chad and Nigeria during COVID-19.
19/10/2020 Synopsis Designing and implementing a monitoring and evaluation framework for seasonal malaria chemoprevention We are developing a monitoring and evaluation framework for SMC to facilitate appraisal of the quality of programme delivery across countries. 19/10/2020 We are developing a monitoring and evaluation framework for SMC to facilitate appraisal of the quality of programme delivery across countries.
29/09/2020 Presentation Adapting SMC in Nigeria during the COVID-19 pandemic: Enhancing safety and minimising risk Our adaptations to our 2020 SMC campaign in Nigeria ensured the continued safe delivery of SMC during the COVID-19 pandemic. 29/09/2020 Our adaptations to our 2020 SMC campaign in Nigeria ensured the continued safe delivery of SMC during the COVID-19 pandemic.
22/09/2020 Synopsis Assessing the feasibility, acceptability and impact of seasonal malaria chemoprevention in Mozambique Our new pilot study will assess the SMC in Nampula province, Mozambique, where SMC is highly seasonal. 22/09/2020 Our new pilot study will assess the SMC in Nampula province, Mozambique, where SMC is highly seasonal.
24/07/2020 Research brief Co-implementing vitamin A supplementation with seasonal malaria chemoprevention: A pilot implementation study in Sokoto state, Nigeria Our pilot implementation study in Nigeria successfully delivered vitamin A supplementation to children under five using the existing SMC campaign. 24/07/2020 Our pilot implementation study in Nigeria successfully delivered vitamin A supplementation to children under five using the existing SMC campaign.
10/06/2020 Advocacy brief Seasonal malaria chemoprevention: An essential health service for Nigeria With global SMC stakeholders, we have developed infection prevention contingency measures for SMC that will greatly reduce the risk of COVID-19 infection. 10/06/2020 With global SMC stakeholders, we have developed infection prevention contingency measures for SMC that will greatly reduce the risk of COVID-19 infection.
05/05/2020 Annual review Seasonal malaria chemoprevention program Philanthropy Report 2019-2020 Malaria Consortium’s annual report on the use of philanthropic funding for SMC. 05/05/2020 Malaria Consortium’s annual report on the use of philanthropic funding for SMC.
29/04/2020 Guidance Adapting seasonal malaria chemoprevention in the context of COVID-19: operational guidance This document provides operational guidance for countries to safely implement SMC in areas where COVID-19 transmission is reported. 29/04/2020 This document provides operational guidance for countries to safely implement SMC in areas where COVID-19 transmission is reported.
16/04/2020 Case study Success story: Delivering seasonal malaria chemoprevention in a rural community in Nigeria Umar Abba Yamel, senior community health extension worker, supervised community distributors and drug management during the 2019 SMC campaign. 16/04/2020 Umar Abba Yamel, senior community health extension worker, supervised community distributors and drug management during the 2019 SMC campaign.
24/03/2020 Learning brief Implementing seasonal malaria chemoprevention in an urban setting In Burkina Faso, we adapted to socio-economic differences and rapid urbanisation to ensure effective SMC campaign delivery in an urban setting. 24/03/2020 In Burkina Faso, we adapted to socio-economic differences and rapid urbanisation to ensure effective SMC campaign delivery in an urban setting.
21/11/2019 Poster Assessing the quality of SMC delivery by low-literate community health workers in Nigeria In 2018, Malaria Consortium trained 20,969 low-literate community health workers in Nigeria to administer SMC to approximately 3.2 million children under five. 21/11/2019 In 2018, Malaria Consortium trained 20,969 low-literate community health workers in Nigeria to administer SMC to approximately 3.2 million children under five.
31/07/2019 Newsletter July 2019 newsletter Our July 2019 newsletter marks the start of a new SMC campaign in the Sahel region, plus the launch of project on films from Uganda and Bangladesh. 31/07/2019 Our July 2019 newsletter marks the start of a new SMC campaign in the Sahel region, plus the launch of project on films from Uganda and Bangladesh.
28/01/2019 Learning paper Seasonal chemoprevention as an effective malaria preventive strategy for children in the Sahel This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel project. 28/01/2019 This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel project.
30/08/2018 Infographic Impact: Malaria Consortium and seasonal malaria chemoprevention Malaria Consortium has been distributing preventive treatments to children under five across the Sahel region to protect them from malaria during the past four rainy seasons. Case-control studies have found… 30/08/2018 Malaria Consortium has been distributing preventive treatments to children under five across the Sahel region to protect them from malaria during the past four rainy seasons. Case-control studies have found that one treatment course of seasonal malaria chemoprevention (SMC) per…
04/05/2018 Presentation Scaling up access to seasonal malaria chemoprevention in the Sahel Diego Moroso, Project Director for ACCESS-SMC, presented the feasibility, safety and effectiveness of seasonal malaria chemoprevention (SMC) at scale at the 2018 Multilateral Initiative on Malaria cConference. There is an… 04/05/2018 Diego Moroso, Project Director for ACCESS-SMC, presented the feasibility, safety and effectiveness of seasonal malaria chemoprevention (SMC) at scale at the 2018 Multilateral Initiative on Malaria cConference. There is an estimated gap of 12 to 18 million children who could…
28/02/2018 Newsletter A catalyst project comes to an end Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and save children’s… 28/02/2018 Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and save children’s lives across seven countries in the Sahel. This final newsletter…
27/02/2018 Case study Gassara’s story: “Health systems risk being overwhelmed by malaria if seasonal malaria chemoprevention is discontinued.” This case study from Chad highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control… 27/02/2018 This case study from Chad highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and…
02/02/2018 Case study Bénédicte’s story: “My children do not get sick during the rainy season anymore.” This case study from Burkina Faso highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria… 02/02/2018 This case study from Burkina Faso highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention…
29/01/2018 Case study Hajara’s story: “If SMC distribution stops, malaria will come back as before.” This case study from Nigeria highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control… 29/01/2018 This case study from Nigeria highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and…
22/11/2017 Poster Transforming the malaria landscape: Results from a three-year implementation research project expanding access to seasonal malaria chemoprevention in seven Sahelian countries Malaria Consortium presented a poster detailing the results from the three-year ACCESS-SMC project at the 10th European Congress on Tropical Medicine and International Health in Antwerp, Belgium from 16–20 October… 22/11/2017 Malaria Consortium presented a poster detailing the results from the three-year ACCESS-SMC project at the 10th European Congress on Tropical Medicine and International Health in Antwerp, Belgium from 16–20 October 2017. The project focused on expanding access to seasonal malaria…
13/11/2017 Technical brief Seasonal malaria chemoprevention at scale: Saving lives Malaria is preventable and treatable, but many children in Africa still die from malaria before their fifth birthday. The ACCESS-SMC project has proven the feasibility, safety and effectiveness of seasonal… 13/11/2017 Malaria is preventable and treatable, but many children in Africa still die from malaria before their fifth birthday. The ACCESS-SMC project has proven the feasibility, safety and effectiveness of seasonal malaria chemoprevention at scale. An estimated gap of 12 to…
29/09/2017 Newsletter ACCESS-SMC September 2017 newsletter Malaria Consortium has achieved high coverage of seasonal malaria chemoprevention in Burkina Faso, Chad and Nigeria. In Burkina Faso and Chad we are even reaching more children than initially targeted.… 29/09/2017 Malaria Consortium has achieved high coverage of seasonal malaria chemoprevention in Burkina Faso, Chad and Nigeria. In Burkina Faso and Chad we are even reaching more children than initially targeted. Read about the major strides the ACCESS-SMC project is making…
31/07/2017 Case study Reaching all children, no matter what ACCESS-SMC is a three-year UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services, which is supporting National Malaria Control Programmes to scale up access to seasonal malaria… 31/07/2017 ACCESS-SMC is a three-year UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services, which is supporting National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention across seven countries in the Sahel. This case study…
18/07/2017 Presentation Exploring community response to seasonal malaria chemoprevention in different contexts At Roll Back Malaria's fourth annual Social Behaviour Change Communication Working Group meeting, Malaria Consortium’s Harriet Kivumbi presented lessons learnt from the UNITAID-funded ACCESS-SMC project, led by Malaria Consortium in… 18/07/2017 At Roll Back Malaria's fourth annual Social Behaviour Change Communication Working Group meeting, Malaria Consortium’s Harriet Kivumbi presented lessons learnt from the UNITAID-funded ACCESS-SMC project, led by Malaria Consortium in partnership with Catholic Relief Services.
18/07/2017 Presentation Mitigating gender and cultural barriers for a successful seasonal malaria chemoprevention campaign in Nigeria At Roll Back Malaria's fourth annual Social Behaviour Change Communication Working Group meeting, Malaria Consortium’s Harriet Kivumbi presented lessons learnt from the UNITAID-funded ACCESS-SMC project, led by Malaria Consortium in… 18/07/2017 At Roll Back Malaria's fourth annual Social Behaviour Change Communication Working Group meeting, Malaria Consortium’s Harriet Kivumbi presented lessons learnt from the UNITAID-funded ACCESS-SMC project, led by Malaria Consortium in partnership with Catholic Relief Services.
29/06/2017 Newsletter ACCESS-SMC June 2017 newsletter ACCESS-SMC brought together leaders in malaria prevention to reach over 6.4 million children in seven countries across the Sahel in 2016. This year, ACCESS-SMC will implement one last season to… 29/06/2017 ACCESS-SMC brought together leaders in malaria prevention to reach over 6.4 million children in seven countries across the Sahel in 2016. This year, ACCESS-SMC will implement one last season to reach roughly 3.9 million children in Burkina Faso, Chad and…
25/04/2017 Newsletter ACCESS-SMC April 2017 newsletter ACCESS-SMC's impact in the fight against malaria has led to seasonal malaria chemoprevention becoming a key intervention in eligible countries' national malaria control strategic plans. Preparation for the 2017 campaign… 25/04/2017 ACCESS-SMC's impact in the fight against malaria has led to seasonal malaria chemoprevention becoming a key intervention in eligible countries' national malaria control strategic plans. Preparation for the 2017 campaign has begun to ensure continued high coverage as donors, governments,…
10/01/2017 Learning brief Seasonal malaria chemoprevention: Transforming the malaria landscape in the Sahel ACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. This learning brief discusses the project’s approach to scaling up seasonal malaria chemoprevention (SMC) and… 10/01/2017 ACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. This learning brief discusses the project’s approach to scaling up seasonal malaria chemoprevention (SMC) and its impact on reducing malaria in children under five across…
23/12/2016 Newsletter ACCESS-SMC December newsletter As the 2016 ACCESS-SMC campaign comes to a close, over six million children in the Sahel region have been successfully administered seasonal malaria chemoprevention. Project Director Diego Morso looks back… 23/12/2016 As the 2016 ACCESS-SMC campaign comes to a close, over six million children in the Sahel region have been successfully administered seasonal malaria chemoprevention. Project Director Diego Morso looks back at what has been accomplished.
29/09/2016 Journal article Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V Background There are few published reports of mutations in dihydropteroate synthetase (dhps) and dihydrofolate reductase (dhfr) genes in P. falciparum populations in Nigeria, but one previous study has recorded a novel… 29/09/2016 Background There are few published reports of mutations in dihydropteroate synthetase (dhps) and dihydrofolate reductase (dhfr) genes in P. falciparum populations in Nigeria, but one previous study has recorded a novel dhps mutation at codon 431 among infections imported to the…
15/09/2016 Journal article The use of formative research to inform the design of a seasonal malaria chemoprevention intervention in northern Nigeria Background Experience of seasonal malaria chemoprevention (SMC) is growing in the Sahel sub-region of Africa, though there remains insufficient evidence to recommend a standard deployment strategy. In 2012, a project was… 15/09/2016 Background Experience of seasonal malaria chemoprevention (SMC) is growing in the Sahel sub-region of Africa, though there remains insufficient evidence to recommend a standard deployment strategy. In 2012, a project was initiated in Katsina state, northern Nigeria, to design an appropriate…
04/07/2016 ACCESS-SMC: SBCC ACCESS-SMC factsheet ACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. The project supports National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention… 04/07/2016 ACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. The project supports National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention across the Sahel. This factsheet provides an introduction to the…
02/07/2016 Newsletter Saving lives in the Sahel In the Sahel region of sub-Saharan Africa, 60 percent of malaria cases occur during the rainy season. Among those most at risk are children under five. Seasonal malaria chemoprevention is… 02/07/2016 In the Sahel region of sub-Saharan Africa, 60 percent of malaria cases occur during the rainy season. Among those most at risk are children under five. Seasonal malaria chemoprevention is a course of medicine that is up to 75 percent…
08/06/2016 Advocacy brief Making the case for seasonal malaria chemoprevention Seasonal malaria chemoprevention (SMC) is a highly effective method of malaria prevention, recommended by the World Health Organization. This advocacy brief makes the case for scaling up SMC across the… 08/06/2016 Seasonal malaria chemoprevention (SMC) is a highly effective method of malaria prevention, recommended by the World Health Organization. This advocacy brief makes the case for scaling up SMC across the Sahel region, discusses the challenges to successful scale-up, and presents…
29/04/2016 Newsletter ACCESS-SMC newsletter As we prepare for the second season of seasonal malaria chemoprevention distribution, Malaria Consortium will hold the first ACCESS-SMC symposium 'Transforming the malaria landscape in the Sahel: Seasonal malaria chemoprevention'. 29/04/2016 As we prepare for the second season of seasonal malaria chemoprevention distribution, Malaria Consortium will hold the first ACCESS-SMC symposium 'Transforming the malaria landscape in the Sahel: Seasonal malaria chemoprevention'.
09/12/2015 Training materials Seasonal malaria chemoprevention programme start-up guide This is a practical guide to planning, implementing and evaluating a sustainable seasonal malaria chemoprevention programme in northern Nigeria, targeting the Nigeria National and State Malaria Elimination Programmes, implementing partners… 09/12/2015 This is a practical guide to planning, implementing and evaluating a sustainable seasonal malaria chemoprevention programme in northern Nigeria, targeting the Nigeria National and State Malaria Elimination Programmes, implementing partners and other stakeholders. It describes the processes, procedures, activities and…
11/10/2013 Project brief Seasonal malaria chemoprevention in Northern Nigeria The project aims to improve child health in Katsina state through increased access to seasonal malaria chemoprevention using community-based delivery systems, and assessing its feasibility for scale up within the… 11/10/2013 The project aims to improve child health in Katsina state through increased access to seasonal malaria chemoprevention using community-based delivery systems, and assessing its feasibility for scale up within the health system.
01/12/2012 Technical brief Seasonal Malaria Chemoprevention (SMC) in Nigeria This briefing note provides background to Seasonal Malaria Chemoprevention in Nigeria. In March 2012, the World Health Organisation (WHO) issued a policy recommendation for a new intervention against Plasmodium falciparum… 01/12/2012 This briefing note provides background to Seasonal Malaria Chemoprevention in Nigeria. In March 2012, the World Health Organisation (WHO) issued a policy recommendation for a new intervention against Plasmodium falciparum malaria - seasonal malaria chemoprevention (SMC), previously referred to as…
View all publications

Sign up for our newsletters here: